NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 97.1 Billion | 85.03 Billion | 87.93 Billion | 81.62 Billion | 83.24 Billion | 66.27 Billion |
| Cost of Revenue | 32.95 Billion | 27.75 Billion | 26.61 Billion | 24.09 Billion | 23.96 Billion | 18.3 Billion |
| Gross Profit | 64.15 Billion | 57.27 Billion | 61.31 Billion | 57.53 Billion | 59.28 Billion | 47.96 Billion |
| Operating Expenses | 40.07 Billion | 35.83 Billion | 38.88 Billion | 35.63 Billion | 36.31 Billion | 28.8 Billion |
| Selling, General and Administrative Expenses | 36.27 Billion | 32.98 Billion | 36.02 Billion | 33 Billion | 33.95 Billion | 26.27 Billion |
| Research and Development Expenses | 2.56 Billion | 2.85 Billion | 2.86 Billion | 2.63 Billion | 2.36 Billion | 2.53 Billion |
| Other Expenses | - | -87.28 Million | 4.19 Million | 129.54 Million | - | -470.00 |
| Cost and Expenses | 71.79 Billion | 63.59 Billion | 65.49 Billion | 59.73 Billion | 60.27 Billion | 47.11 Billion |
| Operating Income | 25.3 Billion | 21.43 Billion | 22.43 Billion | 21.89 Billion | 22.96 Billion | 19.15 Billion |
| Interest Expense | 21.32 Million | 8.84 Million | 38.45 Million | 56.37 Million | 17.16 Million | 2.07 Million |
| Income Tax Expense | 6.16 Billion | 6.29 Billion | 6.12 Billion | 4.8 Billion | 4.29 Billion | 4.41 Billion |
| Earnings before Tax | 29.37 Billion | 23.32 Billion | 23.83 Billion | 22.93 Billion | 23.54 Billion | 19.78 Billion |
| Net Income | 23.21 Billion | 17.02 Billion | 17.71 Billion | 18.13 Billion | 19.24 Billion | 15.36 Billion |
| Earnings Per Share Basic | 1484.00 | 2177.20 | 2264.94 | 2318.34 | 2569.66 | 2172.55 |
| Earnings Per Share Diluted | 2968.15 | 2177.20 | 2264.94 | 2296.43 | 2544.31 | 2149.87 |
| Weighted Average Shares Outstanding | 15.64 Million | 7.82 Million | 7.82 Million | 7.82 Million | 7.48 Million | 7.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.82 Million | 7.82 Million | 7.82 Million | 7.89 Million | 7.56 Million | 7.14 Million |
| Gross Margin | 0.66 | 0.67 | 0.70 | 0.70 | 0.71 | 0.72 |
| EBIT Margin | 0.32 | 0.27 | 0.27 | 0.29 | 0.29 | 0.30 |
| Profit Margin | 0.24 | 0.20 | 0.20 | 0.22 | 0.23 | 0.23 |
| EBITDA | 31.01 Billion | 24.89 Billion | 25.32 Billion | 24.44 Billion | 24.75 Billion | 20.62 Billion |
| Earnings Before Tax Margin | 0.26 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 26.15 Billion | 30.62 Billion | 28.21 Billion | 97.1 Billion | 27.21 Billion | 21.8 Billion |
| Cost of Revenue | - | 13.88 Billion | 11.36 Billion | 32.95 Billion | 10.07 Billion | 7.38 Billion |
| Gross Profit | 26.15 Billion | 16.73 Billion | 16.85 Billion | 64.15 Billion | 17.13 Billion | 14.42 Billion |
| Operating Expenses | 21.06 Billion | 10.62 Billion | 10.06 Billion | 38.84 Billion | 10.2 Billion | 9.36 Billion |
| Selling, General and Administrative Expenses | - | 9.8 Billion | 9.29 Billion | - | 9.68 Billion | 8.7 Billion |
| Research and Development Expenses | - | 816.99 Million | 771.1 Million | - | 513.83 Million | 658.55 Million |
| Other Expenses | -21.06 Billion | 41.86 Million | -68.55 Million | -59.93 Million | 34.13 Million | -29.23 Million |
| Cost and Expenses | 21.06 Billion | 24.51 Billion | 21.42 Billion | 71.79 Billion | 20.27 Billion | 16.74 Billion |
| Operating Income | 5.08 Billion | 6.1 Billion | 6.79 Billion | 25.3 Billion | 6.93 Billion | 5.06 Billion |
| Interest Expense | - | 10.6 Million | 11.74 Million | 21.32 Million | 11.07 Million | 3.92 Million |
| Income Tax Expense | 1.14 Billion | 1.69 Billion | 1.62 Billion | 6.16 Billion | 1.47 Billion | 1.33 Billion |
| Earnings before Tax | 5.47 Billion | 7.57 Billion | 7.73 Billion | 29.37 Billion | 7.48 Billion | 6.26 Billion |
| Net Income | 4.33 Billion | 5.88 Billion | 6.11 Billion | 23.21 Billion | 6 Billion | 4.93 Billion |
| Earnings Per Share Basic | 554.30 | 752.18 | 781.52 | - | 767.68 | 630.54 |
| Earnings Per Share Diluted | 554.30 | 752.18 | 781.52 | - | 767.68 | 630.54 |
| Weighted Average Shares Outstanding | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million | 7.82 Million |
| Gross Margin | 1.00 | 0.55 | 0.60 | 0.66 | 0.63 | 0.66 |
| EBIT Margin | 0.19 | 0.22 | 0.27 | - | 0.27 | 0.25 |
| Profit Margin | 0.17 | 0.19 | 0.22 | 0.24 | 0.22 | 0.23 |
| EBITDA | 5.08 Billion | 6.86 Billion | 7.5 Billion | - | 7.35 Billion | 5.45 Billion |
| Earnings Before Tax Margin | 0.19 | 0.20 | 0.24 | 0.26 | 0.25 | 0.23 |
SAME
002664
ARPC
029530
BPCP
6099